Multiplex Biomarker Imaging Market Phenomenal Growth including key players Bio-Rad Laboratories , US Biomax, Merck KGaA

A new independent 100 page research with title 'Global Multiplex Biomarker Imaging Market (2018–2023)'guarantees you will remain better informed than your competition. The study covers geographic analysis that includes important players/vendors such as Thermo Fisher Scientific, Perkin Elmer, Abcam , Bio-Rad Laboratories , US Biomax, Merck KGaA , Ventana Medical Systems, MicroConstants, Leica Biosystems Nussloch GmbH, ToposNomos , Illumina etc With n-number of tables and figures examining the Multiplex Biomarker Imaging Market, the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2022

Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/1610189-global-multiplex-biomarker-imaging-market-5

The multiplex biomarker imaging market will grow because of its ability to detect the presence of, severity, and exact location of chronic diseases and tumors, along with other applications. According to HTF, the global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018–2023 period, generating a revenue of USD 523.59 Mn by 2023.

The global multiplex biomarker imaging market can be segmented based on:

o Techniques - immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), immunofluorescence (IF), tissue microarray (TMA), and toponome imaging system (TIS)
o Components - instruments, reagents and kits, and software
o Applications - oncology studies, drug safety, genetic characterization, and others (neurodegeneration and protein research)
o End users - research institutes, translational labs, and pharma and biopharma companies

Technique segment insights:

IHC held the largest market share (around 47%) in this segment in 2017. It is widely used in research laboratories and clinical diagnostics, owing to the advantages it offers, vis-à-vis traditional methods of enzyme staining, including specific antigen-antibody reactions. Higher incidence of chronic diseases, especially cancer, is fuelling the need for targeted treatments, thereby contributing to the growth of TMA. The market for TMA is projected to expand at a CAGR of 14.3% during the 2018–2023 period.
Component segment insights:

The instruments section held the largest market share (67%) in 2017, followed by reagents and kits. However, software is predicted to record the fastest expansion (CAGR of 15.0%) during the forecast period (2018–2023), with more automated software packages being made available to researchers. These software modules assist in the research of various diseases and improve the workflow of quantitative analysis.
Place a Purchase Order for this Market Study (Single User License) at: https://www.htfmarketreport.com/buy-now?format=1&report=1610189

Application segment insights:

Multiplex biomarker imaging products are used mostly in oncology studies. This will be followed by drug safety applications, which is expected to expand at a CAGR of 14.1% during 2018–2023.

End user segment insights:

Currently, multiplex biomarker imaging products can only be used for research purposes. Pharma and biopharma companies dominated the market’s end user segment in 2017 with a share of 39%. Meanwhile, translational laboratories are projected to grow at a significant rate during the forecast period.

Regional insights:

The global multiplex biomarker imaging market can be segmented based on regions into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America dominated the global multiplex biomarker imaging market with a share of 50% in 2017, followed by Europe with a 28% share. Asia-Pacific is expected to expand at the highest CAGR (16.0%) during 2018–2023. Across North America and Europe, companies that have software and service agreements for several years are directly selling imaging products to biopharmaceutical companies, laboratories, and academic institutions.

Companies covered:

o Thermo Fisher Scientific, Inc.
o Perkin Elmer, Inc.
o Abcam Plc.
o Bio-Rad Laboratories Inc.
o US Biomax, Inc.
o Merck KGaA
o Ventana Medical Systems, Inc.
o MicroConstants, Inc.
o Leica Biosystems Nussloch GmbH
o ToposNomos Ltd.
o Illumina, Inc.

Customizations available
With the given market data, HTF offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com, or connect with us here.

Request a sample report @ https://www.htfmarketreport.com/sample-report/1610189-global-multiplex-biomarker-imaging-market-5

Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2: Global multiplex biomarker imaging market - overview

2.1. Global market overview - historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), geography-wise market revenue (USD Mn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market challenges
2.4. Global market trends
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key market observations
2.8. Market segmentation based on component (instrument, reagents and kits, software) – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key observations
2.9. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key observations
2.10. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key observations

Chapter 3: North America multiplex biomarker imaging market

3.1. Regional market overview – historical (2015–2017) and forecasted (2018–2023) market size (USD Mn), and key market observations
3.2. Market segmentation based on techniqu

....Continued

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1610189-global-multiplex-biomarker-imaging-market-5

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

Connect with us at
https://www.linkedin.com/company/13388569/
https://www.facebook.com/htfmarketintelligence/
https://twitter.com/htfmarketreport
https://plus.google.com/u/0/+NidhiBhawsar-SEO_Expert?rel=author

This release was published on openPR.